Stockreport

Fresenius Kabi Issues Voluntary Nationwide Recall of Three Lots of Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL Fill in a 2 mL Vial Due to Out-of-Specification Endotoxin ...

FRESENIUS SE S/ADR  (FSNUY) 
NASDAQ:AMEX Investor Relations: fresenius.com/index
PDF Three lots (numbers 6133156, 6133194, 6133388) of Famotidine Injection are being recalled in the U.S. by Fresenius Kabi. Three lots (numbers 6133156, 6133194, 6133388 [Read more]